Filing a Zofran Lawsuit? How Settlement Loans Can Help

Jacky Gale | February 23rd, 2015

Growing numbers of lawsuits have been filed against GlaxoSmithKline (GSK) with regard to their anti-nausea medication, Zofran (ondansetron). Lawsuit allegations link the drug to serious complications, including birth defects and even fetal deaths. Parents have filed complaints to demand compensation from GSK, which would help provide the medical care and rehabilitation services that the surviving children need. Although the litigation process can bring favorable results for families, it can also take months or even years to resolve a case. In the meantime, some plaintiffs who have filed Zofran complaints can rely on lawsuit funding.

Zofran lawsuit funding enables plaintiffs to get the cash they need now, while their case is pending in court. Unlike a traditional bank or credit union loan, lawsuit funding is non-recourse. In fact, it isn’t really a loan at all. It’s a de facto cash advance against a future jury verdict or settlement deal. Essentially, it lets plaintiffs get the cash they rightfully deserve now, when they need it most, instead of waiting for the case to be resolved.

Zofran and birth defects

Typically, parents of children with birth defects and other serious health issues are burdened with significant medical bills and ongoing care expenses. The FDA approved the use of Zofran to treat nausea and vomiting in patients who are recovering from surgery or going through chemotherapy. However, it has also been prescribed for off-label use, such as for pregnant women who are coping with morning sickness. Several recent studies have found that the use of Zofran during pregnancy is linked to a 30 percent increased risk of birth defects, including heart defects, cleft lip, cleft palate, kidney malformations, very low birth weight, and other serious medical problems. It has also been associated with at least two fetal deaths.

According to plaintiffs, GSK declared that Zofran posed no risk to fetuses, despite their own clinical studies demonstrating toxicity, premature births, incomplete bone growth, and intrauterine fetal deaths. At least two Zofran lawsuits accuse GSK of illegally marketing Zofran as a morning sickness drug. While it is legal for doctors to prescribe a medication for off-label use, it is illegal for a drug manufacturer to promote such use. In the past, companies found to have done so have been required by the Justice Department to pay hefty settlements.

Benefits of a Zofran settlement loan

Lawsuit funding for Zofran plaintiffs offers a risk-free way to pay today’s bills out of tomorrow’s settlement. Settlement loans are risk-free because, in the event the plaintiff loses the case, the money never needs to be repaid. This allows parents to give their children the care they desperately need, which may include surgeries and hospitalizations, medications, and rehabilitation services.

However, medical bills aren’t the only expense that plaintiffs could pay with a settlement cash advance. In fact, there are no restrictions on what the money can be used for. It could be used to buy groceries, pay the rent or mortgage, or pay transportation costs, along with any other daily living expenses. Oftentimes, plaintiffs feel pressured to settle their case for less than what they deserve simply to get cash in their pockets sooner. With lawsuit funding, plaintiffs won’t have to settle prematurely.

They can enjoy financial security while their lawsuit is pending.

LawStreet Capital: an industry leader

Zofran plaintiffs who could use a helping hand with legal funding can turn to LawStreet Capital, a company with a longstanding reputation for excellent customer service, low interest rates, and fast approval. Simply fill out our online form or call us at 1-888-557-1637 to learn more. Remember, there is never any risk to you and you could have cash in your pocket in as little as 24 hours after approval.